BerandaORX • STO
add
Orexo AB
Tutup sebelumnya
kr 20,15
Rentang hari
kr 19,10 - kr 20,15
Rentang tahun
kr 9,18 - kr 24,00
Kapitalisasi pasar
697,68Â jt SEK
Volume Rata-Rata
23,48Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 146,20Â jt | 4,95% |
Biaya operasional | 124,70Â jt | -7,36% |
Laba bersih | -15,90Â jt | -78,65% |
Margin laba bersih | -10,88 | -70,27% |
Penghasilan per saham | -0,46 | -76,92% |
EBITDA | 11,90Â jt | -0,83% |
Tarif pajak efektif | 17,19% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 119,10Â jt | -39,85% |
Total aset | 529,00Â jt | -36,26% |
Total liabilitas | 690,30Â jt | -10,18% |
Total ekuitas | -161,30 jt | — |
Saham yang beredar | 34,51 jt | — |
Harga terhadap nilai buku | -4,31 | — |
Tingkat pengembalian aset | 0,36% | — |
Tingkat pengembalian modal | 0,59% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -15,90Â jt | -78,65% |
Kas dari operasi | 32,90Â jt | 274,07% |
Kas dari investasi | -19,20Â jt | -1.500,00% |
Kas dari pembiayaan | -7,00Â jt | -116,17% |
Perubahan kas bersih | -4,10Â jt | -115,19% |
Arus kas bebas | 56,31Â jt | 307,89% |
Tentang
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Didirikan
1995
Situs
Karyawan
110
